EN DE

Sabre Insurance Group (SBRE) Fair Value & Analysis

Financial Services · GB · Market cap 451M GBX

SI Sabre Insurance Group SBRE · LSE
Price£1.86
Fair Value£2.03
Upside+9.3%
Quality64/100
Watch Sabre Insurance Group for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 19.0% net margin
generates free cash flow
6.68% dividend yield
Mixed vs. peers (7/13)
Wide moat 65/100
Evidence: High Range £1.52 – £2.54 Share as image

Fair value as of: Jul 17, 2026

From 6 valuation models · updated 26 days ago

Fair value updated Jul 17, 2026, revised from £2.02 to £2.03 (+0.5%) since Jun 26, 2026. Share price −6.1% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

£2.11 £0.7016 Fair Value £2.03 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range £0.7016 – £2.11 · fair‑value band £1.52 – £2.54 · the £1.86 price screens below the £2.03 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Sabre Insurance Group (SBRE) currently trades at £1.86, while our model-based Fair Value estimate is £2.03, implying the stock looks roughly 9.3% fairly valued today. The Quality Score stands at 64/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Sabre Insurance Group generated revenue of £200M at a net margin of 19.0%. Revenue declined 13.4% year over year. It earns a return on equity of 14.7%. The balance sheet holds a net cash position of £25.5M. Fundamentals as of Jul 17, 2026

Our scenario range runs from £1.52 (bear case) to £2.54 (bull case); at £1.86, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Financial Services peers we cover trades at -38% fair-value upside, at 9%, SBRE screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income £1.00 £1.17 £1.84 76
Gordon GGM £1.16 £1.83 £2.50 70
P/E Multiple £1.52 £2.03 £2.54 63
All 6 models by family
Dividend Discount
Gordon GGM £1.16 £1.83 £2.50 70
DDM Multi-Stage £1.16 £1.63 £2.08 61
Multiples
P/E Multiple £1.52 £2.03 £2.54 63
P/B Multiple £1.11 £1.49 £1.86 55
Asset-Based
NCAV (Graham) £0.5300 £0.7100 £1.06 50
Economic Profit
Residual Income £1.00 £1.17 £1.84 76

Widest divergence: Dividend Discount (£1.63) versus Asset-Based (£0.7100). Highest evidence: Residual Income (76).

Notify me when SBRE reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 200M GBX
Revenue growth (YoY) -13.4%
Net margin 19.0%
Return on equity 14.7%
Free cash flow 43.6M GBX FY2025
P/E ratio 12.4
More key figures
Operating margin 25.7%
EPS (TTM) £0.1500
Dividend yield 6.7%
EPS growth (YoY) -7.4%
Net cash 25.5M GBX FY2025

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 64/100

Of which business quality 62 · Market factors (momentum, volatility) 78

Profitability 48
Margins and returns on capital today
Quality Growth 44
Are margins and returns improving?
Cashflow 73
Earnings quality: real cash, not paper profit
Fin. Strength 64
Balance sheet, leverage, solvency risk
Investment 64
Disciplined investing over empire-building
Low Volatility 91
Calm price path (market factor)
Momentum 73
Price trend over the last 3–12 months (market factor)
52W Momentum 69
Distance to the 52-week high (market factor)
Net Issuance 81
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Sabre Insurance Group plc, through its subsidiaries, writes general insurance for motor vehicles in the United Kingdom. It offers taxi, private car, and motorcycle insurance through a network of insurance brokers, as well as through its Go Girl and Insure 2 Drive brands. Sabre Insurance Group plc was founded in 1982 and is based in Dorking, United Kingdom.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Sabre Insurance Group reported revenue of £230M in FY2025 versus £159M in FY2021, a compound +9.6%/yr. Reported net income was £37.9M in FY2025, compounding +5.9%/yr from FY2021.

Growth Quality 79/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
£230M
Latest YoY
+3.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.6%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.9%
Avg. growth/yr (11Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.8%
Revenue +9.6%/yr
FY21 £159M
FY22 £185M
FY23 £193M
FY24 £223M
FY25 £230M
Net income +5.9%/yr
FY21 £30.1M
FY22 £11.1M
FY23 £18.1M
FY24 £36.0M
FY25 £37.9M
Character of growth · EPS growth decomposed (2014-2025) −8.1 % p.a.
Revenue per share −3.7 pp

of which total revenue +3.3 pp · buybacks/dilution −7.0 pp

EBIT margin −5.3 pp
Tax rate −0.5 pp
Residual (interest, one-offs) +1.6 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch SBRE: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Sabre Insurance Group Fair Value". https://www.fairvalue-calculator.com/stock/SBRE

Peer Group

Insurance Brokers · 36 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 64 · Above median
Fair Value upside +9% · Above median
Return on equity (TTM) 15% · Below median
Return on assets 5% · Below median
Net margin (TTM) 19% · Top 25%
Operating margin (TTM) 26% · Above median
Revenue growth -13% · Bottom 25%
Dividend yield (TTM) 6.7% · Top 25%

Valuation Multiples vs Insurance Brokers median · lower = cheaper

P/E (TTM) 12.4× · Cheaper than median
P/B 2.36× · Cheaper than median
P/S (TTM) 3.04× · Pricier than median
P/FCF 14.0× · Pricier than median
EV/EBITDA 11.6× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 46 · sector 0
FUTURE 0 · sector 66
PAST 59 · sector 60
HEALTH 0 · sector 88
DIVIDEND 100 · sector 50

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Insurance Brokers stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Marsh & McLennan Companies, Inc MRSH $182.18 $112.25 -38%
Aon plc AON $367.21 $224.91 -39%
Arthur J. Gallagher & Co AJG $253.09 $75.58 -70%
Willis Towers Watson Public Limited WTW $285.12 $220.92 -23%
Brown & Brown, Inc BRO $67.66 $40.43 -40%
Erie Indemnity Company ERIE $227.31 $157.43 -31%
PB Fintech Limited POLICYBZR ₹1,574 ₹188.49 -88%
Neptune Insurance Holdings NP $31.03 $3.52 -89%
CorVel Corporation CRVL $62.29 $47.59 -24%
Accelerant Holdings ARX $13.52 $18.06 +34%

Compare Sabre Insurance Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Sabre Insurance Group (SBRE) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of £2.03 versus a price of £1.86, about +9% (fairly valued).
What is the fair value of SBRE?
Our model-based fair value for Sabre Insurance Group is £2.03 (as of Jul 17, 2026), built from audited fundamentals. The current price is £1.86.
What is the quality score of SBRE?
Sabre Insurance Group has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Sabre Insurance Group (SBRE)?
Sabre Insurance Group reported trailing-twelve-month revenue of about £200M (latest available figure, as of Jul 17, 2026).
What is the net profit margin of SBRE?
The net profit margin of Sabre Insurance Group is about 19.0%, meaning it keeps roughly 19.0% of revenue as net income. Based on the latest reported figures.
Does Sabre Insurance Group pay a dividend?
Sabre Insurance Group currently shows a dividend yield of about 8.15% relative to its recent price (as of Jul 17, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Sabre Insurance Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.